Literature DB >> 6138529

Stroke and phenylpropanolamine use.

D A Johnson, H S Etter, D M Reeves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6138529     DOI： 10.1016/s0140-6736(83)90485-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Non-atheromatous causes of cerebral infarction.

Authors:  E M Critchley
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

3.  Ischemic bowel infarction and phenylpropranolamine use.

Authors:  D A Johnson; P W Stafford; R J Volpe
Journal:  West J Med       Date:  1985-03

4.  Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America.

Authors:  Albert Figueras; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.